益生菌Enterococcus Faecium的代谢物表征,以向导致胃肠炎的肠道细菌沙门氏菌
Kashef Choudhary1, Muhammad Naveed2, Tariq Aziz3
1Department of Biotechnology, Faculty of Science and Technology, University of Central Punjab, Lahore, 54590, Pakistan.
Antonie van Leeuwenhoek
|October 23, 2025
概括
菌菌的代谢物显示出强大的抗微生物,抗氧化,抗糖尿病和抗炎作用对沙门氏菌. 这些发现强调了它们在治疗胃肠炎和相关代谢障碍方面的潜力.
科学领域:
- 微生物学 微生物学
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 胃肠炎是全球常见的健康问题,由病原性细菌引起,如沙门氏菌.
- 益生菌对胃肠道疾病具有治疗潜力,因为它们对肠道健康有有益的影响.
研究的目的:
- 研究Enterococcus faecium代谢物对Salmonella enterica的抗微生物,抗氧化,抗糖尿病和抗炎性质.
主要方法:
- 细菌菌株 (Enterococcus faecium,Salmonella enterica) 用16SrRNA测序进行了分离和鉴定.
- 通过使用各种溶剂从Enterococcus faecium提取代谢物.
- 使用光盘扩散评估了抗微生物活性;使用DPPH,α-amylase抑制和蛋白质变性测试分别评估了抗氧化,抗糖尿病和抗炎活性.
主要成果:
- 菌的代谢物显示出对沙门氏菌的剂量依赖的抗微生物活性.
- 最大抗氧化剂清除率为99.8% (DPPH测定).
- 观察到显著的抗糖尿病 (84.66%的α-氨基酶抑制) 和抗炎症 (99%的蛋白质变性抑制) 活性.
结论:
- 菌的代谢物具有显著的体外抗菌,抗氧化,抗糖尿病和抗炎性质.
- 这些代谢物对管理沙门氏菌引起的胃肠炎和相关代谢障碍有前途.
- 对于临床应用,需要进一步的研究.
关键词:
肠球菌 (Enterococcus faecium) 是一个有毒的菌株.沙门氏菌 (Salmonella enterica) 已经成为一种常见的疾病.具有抗炎作用的抗炎作用.抗微生物活性的抗菌活性.胃肠炎是一种胃肠炎.更多相关视频
06:58Analysis of Interactions between Endobiotics and Human Gut Microbiota Using In Vitro Bath Fermentation Systems
Published on: August 23, 2019
7.5K
09:26Identification of Antibacterial Immunity Proteins in Escherichia coli using MALDI-TOF-TOF-MS/MS and Top-Down Proteomic Analysis
Published on: May 23, 2021
3.6K
相关概念视频
01:22Probiotics
Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
01:18Bacterial Gastroenteritis
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...